2006
DOI: 10.1016/j.canrad.2006.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Medulloblastoma with extracentral nervous system metastases: clinical presentation and risk factors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 22 publications
0
8
0
Order By: Relevance
“…11,12 The prognosis for patients with extra-neuraxial metastases of medulloblastoma remains extremely poor, with a reported mean survival of 6-9 months. 4,6 The treatment options for systemic medulloblastoma are limited. Chemo-naïve patients should be offered palliative systemic chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…11,12 The prognosis for patients with extra-neuraxial metastases of medulloblastoma remains extremely poor, with a reported mean survival of 6-9 months. 4,6 The treatment options for systemic medulloblastoma are limited. Chemo-naïve patients should be offered palliative systemic chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…Since the original report of cerebellar medulloblastoma with systemic metastases, 3 several such single case reports and case series have been published. [4][5][6] Bone (77%) is the most frequent site of systemic metastases, 4 followed by lymph nodes (33%), bone marrow (20%), lung (17%) and liver (15%). Bony lesions usually involve the axial skeleton, pelvic and shoulder girdle, adjacent ends of long bones, ribs and skull.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The commonest involved sites are bone, bone marrow and cervical lymph nodes. A complete workup at initial diagnosis is recommended to screen for early metastases [109]. Extracranial dissemination is a very poor prognostic sign and requires aggressive systemic therapy for disease control [91].…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies 9,10 report that the systemic metastases can occur from 3 to 5% of the medulloblastoma population, but there is a lack of reports concerning some aspects of the disease, as histological type, tumor topography and survival rate. These blanks in the details of patients with systemic metastasis of medulloblastoma leave incomplete the clinical profile or the natural history of this severe condition.…”
Section: Discussionmentioning
confidence: 99%